If you combine the growth of a small company with the financial muscle of a large company and put them in a single syringe, you get Gilead Sciences (GILD), an emerging giant of the biotech world. Based in the Bay Area of California, GILD discovers, develops and markets drugs for patients suffering from HIV, Hepatitis B and other life-threatening illnesses. I like their current drug portfolio, but I am just as impressed with its pipeline of new therapies.